Barazeghi, E., Hellman, P., Norlén, O., Westin, G., & Stålberg, P. (2021). EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine. Nature Portfolio.
Cita Chicago Style (17a ed.)Barazeghi, Elham, Per Hellman, Olov Norlén, Gunnar Westin, y Peter Stålberg. EZH2 Presents a Therapeutic Target for Neuroendocrine Tumors of the Small Intestine. Nature Portfolio, 2021.
Cita MLA (8a ed.)Barazeghi, Elham, et al. EZH2 Presents a Therapeutic Target for Neuroendocrine Tumors of the Small Intestine. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.